Effect of frailty on prognosis in patients with metastatic urothelial carcinoma(FRAmUC study)
Not Applicable
Recruiting
- Conditions
- metastatic urothelial carcinoma
- Registration Number
- JPRN-UMIN000039881
- Lead Sponsor
- Hirosaki University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with metastatic urothelial carcinoma who were not treated with standard of care or no frailty evaluation.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome was the effect of frailty on progression-free survival in patients with metastatic urothelial carcinoma
- Secondary Outcome Measures
Name Time Method Secondary outcomes included safety, progression-free survival, and overall survival.